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Abstract
When located in the endoplasmic reticulum (ER) membrane, B-cell receptor associated pro-
tein 31 (BAP31) is involved in the export of secreted proteins from the ER to the plasma
membrane. In a previous study, we generated two monoclonal antibodies (mAbs), 297-D4
and 144-A8, that bound to surface molecules on human embryonic stem cells (hESCs), but
not to surface molecules on mouse embryonic stem cells (mESCs). Subsequent studies
revealed that the mAbs recognized BAP31 on the surface of hESCs. To investigate the
membrane topology of BAP31 on the cell surface, we first examined the epitope specificity
of 297-D4 and 144-A8, as well as a polyclonal anti-BAP31 antibody (α-BAP31). We gener-
ated a series of GST-fused BAP31 mutant proteins in which BAP31 was serially deleted at
the C- terminus. GST-fused BAP31 mutant proteins were then screened to identify the epi-
topes targeted by the antibodies. Both 297-D4 and 144-A8 recognized C-terminal residues
208–217, while α-BAP31 recognized C-terminal residues 165–246, of BAP31 on hESCs,
suggesting that the C-terminal domain of BAP31 is exposed on the cell surface. The poly-
clonal antibody α-BAP31 bound to mESCs, which confirmed that the C-terminal domain of
BAP31 is also exposed on the surface of these cells. Our results show for the first time the
novel membrane topology of cell surface-expressed BAP31 as the extracellular exposure of
the BAP31 C-terminal domain was not predicted from previous studies.
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Introduction
B-cell receptor-associated protein 31 (BAP31) is known to be a 28 kDa integral endoplasmic
reticulum (ER) membrane protein that is expressed ubiquitously [1–3]. Composed of three
membrane-spanning segments and a 13 kDa cytoplasmic tail containing an extended coiled-
coil region [4], BAP31 promotes the vesicular transport of transmembrane proteins, such as
class I major histocompatibility complex, immunoglobulin D, cellubrevin, teteraspanins, cyto-
chrome P450, and CD11b/CD18 [5–11]. Thus, BAP31 is a chaperone/quality control factor
that participates in the transport and quality control of membrane proteins. Many studies have
also shown that the C-terminus of BAP31 is exposed on the cytoplasmic side of the ER and
cleaved by caspase-8 in response to apoptosis-inducing stimuli [3, 4, 6, 8, 12–16]. The mito-
chondrial protein Fis1 and BAP31 complex that spans the mitochondria–ER interface serves as
a platform to activate the initiator procaspase-8 [14, 15]. During apoptosis, the exposed C-ter-
minus of BAP31 are targeted by caspases, and the cleavage product, p20BAP31, which remains
in the ER membrane, transmits the apoptosis signal [17]. Thus, BAP31 is also an important
regulator of apoptosis on the ER membrane.
We previously generated monoclonal antibodies (mAbs) against surface molecules of
human embryonic stem cells (hESCs) using a modified decoy immunization strategy [18].
Among the mAbs produced, 297-D4 recognized BAP31 on the surface of hESCs and some can-
cer cell lines, including A375 (human malignant melanoma), SH-SY5Y (human neuroblas-
toma), Colo-205 (human colon carcinoma), and HepG2 (human hepatocellular carcinoma)
[19]. Subsequent studies revealed that BAP31 positively regulates hESC adhesion, stemness,
and survival by interacting with epithelial cell adhesion molecule (EpCAM) on the surface
[19]. To investigate the membrane topology of BAP31 on the cell surface, we first examined
the epitope specificity of 297-D4 for BAP31. Epitope mapping of 297-D4 and two other anti-
BAP31 antibodies suggests that the C-terminal domain of cell surface-expressed BAP31 is
exposed on the extracellular side. The result is unexpected because the cytoplasmic side of ER
membrane proteins is generally preserved even after translocation to the plasma membrane
[20]. To our knowledge, this is the first report showing the unexpected membrane topology of
cell surface-expressed BAP31.
Materials and Methods
Cell Cultures
H9 hESC line (WiCell, Madison, WI, USA) was cultured on irradiated mouse embryonic
fibroblast (MEF) feeder cells as described previously [18, 19, 21]. Briefly, hESCs were
maintained in DMEM/F12 medium supplemented with 20% Knockout serum replacement
(Invitrogen, Seoul, Korea), 0.1 mM 2-mercaptoethanol, 1% non-essential amino acid, 1 mM
glutamine, 100 U/ml penicillin G, 100 μg/ml streptomycin, and 4 ng/ml basic fibroblast growth
factor (PeproTech, Rocky Hill, NJ, USA). hESCs were subcultured every 5 days with 1 mg/ml
collagenase IV (Invitrogen, Seoul, Korea). Mouse embryonic stem cell (R1) line was cultured
and maintained as described previously [19, 21].
Preparation and induction of GST-fusion protein
Serially truncated BAP31 proteins were expressed as fusion proteins with GST proteins. The
coding sequences of serially truncated and whole BAP31 genes were synthesized by polymerase
chain reaction from the BAP31-myc-KKEE plasmid using 5’-primer and various 3’-primers
and subcloned into the EcoRI/SalI sites of pGEX4T-2 (GE Healthcare, Seoul, Korea) to yield
the expression plasmids [22]. All primer sequences are listed in Table 1. Each expression
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plasmid was confirmed by DNA sequencing, and introduced into E. coli DH5α cells to express
the GST-BAP31 fusion proteins. The expression of the fusion proteins was induced by 0.1 mM
isoprophyl-β-D-thiogalactopyranoside at 32°C for 6 h. The induced bacterial cells were washed
with pre-chilled phosphate-buffered saline (PBS, pH 7.4), incubated with acetone on ice for
5 min, and lysed in 1% SDS supplemented with 100 μg/ml phenylmethanesulfonyl fluoride
(PMSF) for 2 min at room temperature (RT). Proteins were clarified by centrifugation, and
their concentration was measured by bicinchoninic assay (Thermo Scientific, Rockport, IL,
USA). The cell lysates were subjected to 12.5% SDS-PAGE, stained with Coomassie brilliant
blue R-250, and analyzed by western blot analysis [23].
Flow Cytometry
Flow cytometric analysis was performed using antibodies as described previously [18, 19, 21].
Briefly, H9 hESCs were incubated with appropriate primary antibodies for 30 min at 4°C.
The primary antibodies used were anti-TRA-1-60, anti-TRA-1-81, α-BAP31 (Santa Cruz
Biotechnology sc-48766, Santa Cruz, CA, USA), goat anti-BAP31 (Santa Cruz Biotechnology
sc-18579), mouse anti-BAP31 (Santa Cruz Biotechnology sc-365347), 297-D4, or 144-A8
antibodies. The cells were then further incubated with fluorescein isothiocyanate (FITC)-con-
jugated anti-mouse IgG, anti-rabbit IgG, anti-goat IgG, or anti-mouse IgM (BD Biosciences) in
PBA (1% bovine serum albumin, 0.02% NaN3 in PBS), depending on the isotype of the pri-
mary antibodies. Propidium iodide (PI, 25 μg/ml) was used to detect and eliminate dead cells
from the samples. Negative cells for PI staining were gated to exclude the dead cells and ana-
lyzed on a Becton-Dickinson FACSCalibur.
Antibody-antibody competition binding assay
H9 hESCs were pre-incubated with 5 μg/ml of isotype control antibody, α-BAP31, or biotin-
labeled 297-D4 at 4°C for 30 min. The cells were then incubated with 2 μg/ml of competing
antibodies 297-D4 and 144-A8 for α-BAP31 binding, or 2 μg/ml of 144-A8 for biotin-labeled
297-D4 binding at 4°C for 30 min. Antibody binding was measured by flow cytometric
analysis. The secondary antibodies used were Alexa 488-conjugated rabbit IgG or phycoery-
thrin-conjugated streptavidin. The percent of binding inhibition was calculated from mean
fluorescence intensity. The percent inhibition of competing antibodies was normalized against
each antibody binding in the presence of isotype control antibody. The graph presents the
mean values of at least three independent determinations ± standard deviation. Statistical anal-
ysis used the Student’s t-test.
Table 1. Primer sequence for the generation of BAP31 deletionmutants.
N-terminus CCT GAA TTC CCA TGA GTC TGC AGT GGA CT
C-terminus
124 CGT GTC GAC TTA CGA AAT GAG AGT CAC
164 CAA GTC GAC TTA GTC AAC AGC AGC TCC
207 GGC GTC GAC TTA GTT TTC AGC TTT CTC
217 CTT GTC GAC TTA CTC AGA CTG CTT
227 TGC GTC GAC TTA CAG CAA GCG GTC
237 CAT GTC GAC TTA TAC TGC AGC CTG
245 AGG GTC GAC TTA TTC CTT CTT GTC
246 AGG GTC GAC TTA CTC TTC CTT CTT GTC
doi:10.1371/journal.pone.0130670.t001
The Novel Membrane Topology of BAP31
PLOSONE | DOI:10.1371/journal.pone.0130670 June 23, 2015 3 / 13
Cell surface biotinylation, immunoprecipitation, and western blotting
Cell surface biotinylation, immunoprecipitation, and western blotting were performed as
described previously [18, 19, 21]. Briefly, biotin-labeled H9 hESCs or R1 mESCs were treated
with lysis buffer (25 mM Tris-HCl, pH 7.5, 250 mMNaCl, 5 mM EDTA, 1% Nonidet P-40,
2 μg/ml aprotinin, 100 μg/ml PMSF, 5 μg/ml leupeptin, and 1mMNaF) at 4°C for 30 min, and
nuclei were removed by centrifugation. To immunoprecipitate the antigens recognized by the
antibodies, the lysates were pre-cleared with Protein G plus-Sepharose (Santa Cruz Biotechnol-
ogy, Santa Cruz, CA, USA), incubated with 297-D4, 144-A8 or α-BAP31 at 4°C overnight, and
further incubated with Protein G plus-Sepharose. The bound proteins were eluted from the
beads by heating at 100°C for 10 min after extensive washing with lysis buffer. Eluted proteins
were fractionated by SDS-PAGE and then transferred to a nitrocellulose membrane for western
blotting. The membrane was blocked in 5% skim milk in PBST (PBS containing 0.1% Tween
20) at RT for 1 h and incubated with SA-HRP (GE Healthcare, Seoul, Korea) at RT for 1 h. The
biotinylated proteins were visualized using the ECL detection reagent (GE Healthcare, Seoul.
Korea) after extensive washing. For western blot analysis, proteins on polyacrylamide gels were
transferred to a nitrocellulose membrane and incubated with 297-D4, 144-A8, or α-BAP31
antibodies followed by HRP-conjugated anti-mouse IgG or anti-rabbit IgG for 1 h at RT as
described before [19]. The membranes used were stripped at 50°C for 30 min in stripping
buffer (62.5 mM Tris-Cl, pH6.7, 100 mM 2-mecaptoethanol, 2% SDS). The membranes were
then washed and subjected to western blotting again. The immunoblots were visualized as
described above.
Results
Two mAbs 297-D4 and 144-A8 recognize cell surface-expressed BAP31
In a previous study, we generated a panel of mAbs against the surface molecules of hESCs and
found that the mAb 297-D4 (IgG1, κ) recognizes BAP31 on the surface of hESCs [18, 19], sug-
gesting that BAP31, an ER resident protein, is also expressed on the cell surface. To confirm
that BAP31 is expressed on the cell surface of hESCs, the cell surface molecules of hESCs were
biotinylated and subjected to immunoprecipitation and western blotting with 297-D4 and α-
BAP31, a commercially available rabbit polyclonal antibody against BAP31. Another mAb
144-A8 (IgG1, κ), an independently isolated mAb against a surface molecule of hESCs, was
also included in this analysis. Proteins immunoprecipitated with 297-D4, 144-A8, or α-BAP31
were readily detected by western blot analysis with 297-D4, 144-A8, or α-BAP31 (Fig 1A, the
first, second, and third panels), indicating that both 297-D4 and 144-A8 recognize the BAP31
protein. The immunoprecipitated BAP31 proteins were also detected by horseradish peroxi-
dase-conjugated streptavidin (SA-HRP) (Fig 1A, the fourth panel), indicating that the BAP31
proteins recognized by the three antibodies are expressed on the cell surface. Flow cytometric
analysis with propidium iodide (PI)-negative hESCs also revealed that the BAP31 proteins rec-
ognized by the two mAbs and α-BAP31 are expressed on the surface of hESCs (Fig 1B). Thus,
the results indicate that the two mAbs, 297-D4 and 144-A8, and α-BAP31 recognize cell sur-
face-expressed BAP31.
Fine epitope mapping of 297-D4, 144-A8, and α-BAP31
Previous studies have shown that BAP31 has three transmembrane domains within its amino
terminus, and the short hydrophilic amino terminus of BAP31 is exposed in the ER lumen
while the 13 kDa C-terminal domain of BAP31 is exposed on the cytoplasmic side [3, 4, 6, 8,
12–16]. Therefore, we expected that cell surface-expressed BAP31 would have the same
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membrane topology, i.e., with a cytoplasmic C-terminal domain. However, cell surface-
expressed BAP31 was recognized in immunoprecipitation and flow cytometric analysis by
α-BAP31, which was raised against residues (157–246) mapping within the C-terminal cyto-
plasmic domain of BAP31 (Fig 1A and 1B). The results imply that the C-terminal domain of
BAP31 is not located in the cytoplasm, but is exposed on the cell surface when the protein
localizes on the plasma membrane. 297-D4 and 144-A8 also recognized cell surface-expressed
BAP31 (Fig 1B), suggesting that the epitopes of both mAbs are also located on the C-terminal
domain of BAP31. To determine the exact epitopes of 297-D4, 144-A8, and α-BAP31, a series
of C-terminal deletion mutants of BAP31 gene were synthesized by PCR and fused to glutathi-
one S-transferase (GST) gene to construct a series of expression plasmids (Fig 2A). Each
plasmid was introduced into E. coli, and the protein extracts of the recombinant cells were ana-
lyzed by SDS-PAGE. The expression of serial deletion mutants of BAP31 were visualized by
Coomassie Blue staining and analyzed by western blot analysis with an anti-GST antibody. All
serial deletion mutants of GST-BAP31 fusion proteins were readily expressed and detected
(Fig 2B and 2C). The partially degraded forms of the serial deletion mutants of GST-BAP31
fusion proteins were also detected below the main GST-BAP31 fusion proteins (Fig 2C). The
same recombinant E.coli lysates were then subjected to western blot analysis with 297-D4,
which recognized the full-length form (residues 1–246), but not the deletion mutant forms
(residues 1–207, 1–164, 1–158, and 1–124) (Fig 2D). The same result was also obtained with
144-A8 (Fig 2E). The results suggest that 297-D4 and 144-A8 recognize the linear epitopes
located between residues 208–246 of BAP31. The polyclonal antibody α-BAP31 recognized the
full length and the deletion mutant with residues 1–207, but not the deletion mutants (residues
1–124, 1–158, and 1–164) (Fig 2F), suggesting that the epitopes of α-BAP31 are within the res-
idues 165–246 of BAP31.
To find the fine epitopes of 297-D4, 144-A8, and α-BAP31, residues 207–246 of BAP31
were further dissected and expressed as GST-BAP31 fusion proteins. The expression of the
BAP31 deletion mutants (residues 1–207, 1–217, 1–227, 1–237, 1–245, and 1–246) of
GST-BAP31 proteins were confirmed by western blot analysis with an anti-GST antibody
(Fig 3A, 3B and 3C). The partially degraded forms of the serial deletion mutants of
GST-BAP31 fusion proteins were again detected below the main GST-BAP31 fusion proteins
(Fig 3C). 297-D4 recognized the serial deletion mutants (residues 1–217, 1–227, 1–237, 1–245
and 1–246), except for residues 1–207 (Fig 3D). The same result was also obtained with
144-A8 (Fig 3E). The results indicate that 297-D4 and 144-A8 recognize the linear epitopes
Fig 1. MAb 297-D4 andMAb 144-A8 recognize BAP31 on the cell surface of hESCs. (A)
Immunoprecipitation of biotinylated hESCs with α-BAP31, 297-D4, and 144-A8 antibodies.
Immunoprecipitates were detected by western blots with the indicated antibodies or SA-HRP. (B) Flow
cytometric analysis of hESCs with anti-TRA-1-60, α-BAP31, 297-D4, or 144-A8 antibodies.
doi:10.1371/journal.pone.0130670.g001
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between residues 208–217 of BAP31. The polyclonal antibody α-BAP31 recognized all deletion
mutants (residues 1–207, 1–217, 1–227, 1–237, 1–245 and 1–246), although it did not recog-
nize the deletion mutants (residues 1–124, 1–158 and 1–164) (Figs 2F and 3F), confirming
that the epitopes of α-BAP31 are scattered throughout the residues 165–246 of BAP31.
297-D4 and 144-A8 compete with each other
Both 297-D4 and 144-A8 recognized the residues 208–217 of BAP31 in the epitope mapping
analysis. To further confirm whether the two mAbs recognize the overlapping epitope on the
native BAP31 protein, we performed antibody competition binding assay by using flow cyto-
metric analysis. hESCs were preincubated with biotinylated 297-D4 before the addition of
competing antibody 144-A8. 297-D4 binding was inhibited by approximately 49% with
144-A8 (Fig 4A), indicating that the two mAbs have overlapping epitopes on the native BAP31
protein. When hESCs were preincubated with α-BAP31 before the addition of competing anti-
bodies 297-D4 or 144-A8, α-BAP31 binding was also inhibited by approximately 42% with
both antibodies (Fig 4B and 4C). The result suggests that the predominant epitope recognized
by the polyclonal α-BAP31 overlapped with the epitopes of 297-D4 and 144-A8.
Mouse Bap31 is also expressed on the surface of mESCs
We found by using 297-D4 that BAP31 is expressed on the surface of hESCs, but not on the
surface of mESCs [19], suggesting that mouse Bap31 is not expressed on the surface of mESCs.
However, sequence alignment showed that the residues at 209 and 213, within the epitope of
297-D4, were different between human BAP31 and mouse Bap31 (Fig 5A). Therefore, we
Fig 2. Epitopemapping of 297-D4, 144-A8, and α-BAP31 antibodies. (A) Schematic diagram of
recombinant BAP31 fragments (residues 1–124, 1–158, 1–164, 1–207, and 1–246) used in this study. (B)
Individual fusion proteins were expressed in bacteria as fusion proteins with GST tag at the N-terminus and
stained with Coomassie brilliant blue after SDS-PAGE. (C-F) Western blot analysis of GST-BAP31 fusion
proteins with anti-GST (C), 297-D4 (D), 144-A8 (E), and α-BAP31 (F) antibodies. The asterisks indicate
partial degradation products of GST-BAP31 fusion proteins.
doi:10.1371/journal.pone.0130670.g002
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postulate that Bap31 is expressed on the surface of mESCs, as well, but it is not detected due
to the sequence difference between human and mouse BAP31. Although the epitope of the poly-
clonal α-BAP31 overlapped with the epitope of 297-D4, its binding to hESCs was not completely
inhibited by 297-D4. This suggests that some epitopes recognized by the polyclonal α-BAP31 are
outside of the epitope of 297-D4. As shown in Fig 1A and 1B, cell surface-expressed BAP31 on
Fig 3. Fine epitopemapping of 297-D4, 144-A8, and α-BAP31 antibodies. (A) Schematic diagram of
recombinant BAP31 fragments (residues 1–207, 1–217, 1–227, 1–237, 1–245, and 1–246) used in this study.
(B) Individual fusion proteins were expressed in bacteria as fusion proteins with GST tag at the N-terminus
and stained with Coomassie brilliant blue after SDS-PAGE. (C-F) Western blot analysis of GST-BAP31
fusion proteins with anti-GST (C), 297-D4 (D), 144-A8 (E), and α-BAP31 (F) antibodies. The asterisks
indicate partial degradation products of GST-BAP31 fusion proteins.
doi:10.1371/journal.pone.0130670.g003
Fig 4. Antibody-antibody competition binding assay. (A) hESCs were preincubated with biotinylated
297-D4 in the presence of isotype control antibody and 144-A8 prior to the addition of phycoerythrin-
conjugated streptavidin. (B,C) hESCs were preincubated with α-BAP31 in the presence of isotype control
antibody, 297-D4 (B), 144-A8 (C) prior to the addition of FITC-conjugated anti-rabbit IgG. Antibody binding to
hESCs was then analyzed by flow cytometry. The percent of binding inhibition was calculated frommean
fluorescence intensity. Statistical analysis used the Student’s t-test (*p<0.05; **p<0.001).
doi:10.1371/journal.pone.0130670.g004
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hESCs was recognized by α-BAP31. Therefore, we examined the surface expression of Bap31 on
mESCs by using the polyclonal α-BAP31 antibody. As expected, α-BAP31 was able to bind to
mESCs but 297-D4 was not (Fig 5B). To further confirm whether Bap31 is also expressed on the
surface of mESCs, cell surface proteins of mESCs were biotinylated and subjected to immunopre-
cipitation and western blotting with α-BAP31, 297-D4, or 144-A8. α-BAP31 alone was able to
immnunoprecipitate Bap31 frommESCs (Fig 5C left, the second, third, and fourth panels).
SA-HRP staining further confirmed that α-BAP31 alone was able to recognize and immunopre-
cipitate mouse Bap31 on the cell surface (Fig 5C left, the first panel). Thus, the results confirm
that BAP31 is expressed on the surface of both hESCs and mESCs.
Proposed model for cell surface-expressed BAP31
BAP31 contains three transmembrane domains within its amino terminus that provide topol-
ogy in the ER membrane; the short amino terminus of BAP31 is exposed in the ER lumen, and
the 13 kDa C-terminal domain of BAP31 is exposed on the cytoplasmic side [3, 8, 13, 15]. The
same membrane topology of BAP31 was expected in the plasma membrane because the cyto-
plasmic side of ER membrane proteins is usually preserved after translocation to the plasma
membrane [20]. Our results indicate, however, that the C-terminal domain of BAP31 is not
located in the cytoplasm but is exposed on the cell surface. To further confirm whether the
C-terminal domain of BAP31 is exposed on the cell surface, we analyzed the cell surface expres-
sion of BAP31 on H9 hESCs by flow cytometric analysis with various concentrations of α-
BAP31, a goat polyclonal anti-BAP31 antibody (specific for the internal region), or a mouse
Fig 5. BAP31 is also expressed on the surface of mESCs. (A) The epitope sequences of 297-D4 and
144-A8 are different between hESCs and mESCs. The partial C-terminal amino acid sequences were aligned
between human and mouse BAP31. The epitope sequences are underlined, and the different amino acids
are indicated by arrows. (B) Flow cytometry analysis of mESCs with anti-SSEA-1, 297-D4, 144-A8, and α-
BAP31 antibodies. (C) Immunoprecipitation of mESCs with 297-D4, 144-A8, and α-BAP31 antibodies. Cell
surface proteins of mESCs were biotinylated, immuoprecipitated, and analyzed by SA-HRP or western blot
with α-BAP31 (left panels). The input samples were also analyzed by western blots (right panels). β-actin was
used as a loading control.
doi:10.1371/journal.pone.0130670.g005
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monoclonal anti-BAP31 antibody (specific for residues 137–161). Epitope analysis showed that
the goat polyclonal anti-BAP31 antibody recognized residues 125–158 in the western blot anal-
ysis (S1 Fig). The cell surface expression of BAP31 was detected in 98% of the total population
with α-BAP31, while it was hardly detected with the goat and mouse antibodies (Fig 6). The
results indicate that the C-terminal domain of BAP31 from residues 165–246 is exposed and
recognized by α-BAP31 on the cell surface, while the C-terminal domain from residues 125–
161 is not recognized by the goat and mouse antibodies.
Next, we predict and propose a new membrane topology for cell surface-expressed BAP31,
based on the present study and server-based computing program (www.predictprotein.org)
(Fig 7 and Table 2). The new topology suggests that the cytosolic regions of BAP31 are amino
acid residues 1–10 and 64–104, and the extracellular regions are amino acid residues 30–45
and 123–246. According to the amino acids’ characteristics (e.g., hydrophobicity, hydrophilic-
ity) the computing program detected three membrane helices and two loops for the best
model. Although the sidedness of BAP31 C-terminal domain is different between the ER mem-
brane and the plasma membrane, the structure of the three membrane helices and the two
loops is consistent with the previous finding [3]. On the other hand, the present antibody
Fig 6. Flow cytometric analysis of the percent expression of cell surface-expressed BAP31 on H9
hESCs. The cell surface expression of BAP31 was examined by flow cytometric analysis with various
concentrations (1, 5, or 10 μg/ml) of rabbit (residues 165–246), goat (residues 125–158), or mouse (residues
137–161) anti-BAP31 antibodies. Shown are the percentages of BAP31-positive cells at the concentration of
10 μg/ml of antibodies.
doi:10.1371/journal.pone.0130670.g006
Fig 7. Proposedmodel for the membrane topology of BAP31 on the cell surface of hESCs and
mESCs.
doi:10.1371/journal.pone.0130670.g007
The Novel Membrane Topology of BAP31
PLOSONE | DOI:10.1371/journal.pone.0130670 June 23, 2015 9 / 13
studies also suggest the possibility that the C-terminal domain from residues 125–161 is not
available to antibodies on the cell surface, although the domain is predicted to be on the extra-
cellular side of the plasma membrane.
Discussion
We previously found that BAP31 is expressed on the surface of hESCs, [19] despite the fact
that the protein is known as a chaperone and quality control factor mainly located in the ER
membrane [1–3, 5, 11, 19, 24, 25]. BAP31 contains a KKEE ER retention signal at its C termi-
nus, although some studies showed that mutation of the KKEE sequence does not alter the ER
distribution of BAP31 [1, 3, 11]. We also attempted to find any alterations in BAP31 sequences
that are involved in the translocation of BAP31 into the plasma membrane of hESCs. We
cloned and sequenced 19 BAP31 cDNAs from H9 hESCs and NT-2/D1, and found that most
clones had normal standard BAP31 sequences (data not shown). Although we found some spo-
radic point mutations in some clones, they were not consistent among the different clones,
which suggest that the mutations are minor variants or artifacts. Thus, we could not find any
major variant forms of BAP31 that could be responsible for the translocation to the plasma
membrane of hESCs.
We found that cell surface translocation of BAP31 was not limited to hESCs. By flow cytom-
etry, we could detect BAP31 on the surface of some cancer cell lines, such as A375, SH-SY5Y,
Colo-205, and HepG2 [19]. A low level of BAP31 was also detected on the surface of U87-MG,
NCI-H69, and A549 cells [19]. Previous studies also showed that a small portion of BAP31 is
located at the plasma membrane of human colonic epithelial cells and human foreskin fibro-
blast [8, 26]. Therefore, it is conceivable that BAP31 protein may be initially inserted into the
ER membrane, but a small portion of BAP31 protein may be translocated into the plasma
membrane, depending on the cell type.
In this study, we found that two mAbs, 297-D4 and 144-A8, recognized cell surface-
expressed BAP31 (Fig 1), and their epitopes are located between residues 208–217 of BAP31
(Figs 2D, 2E, 3D and 3E). The results suggest that the C-terminal domain of cell surface-
expressed BAP31 is exposed on the extracellular side. We also found that cell surface-expressed
BAP31 was recognized by the commercial polyclonal α-BAP31 antibody. Information from
the supplier indicates that α-BAP31 was raised against residues 157–246 of BAP31, and the
present study further defined that the epitope for this polyclonal antibody was scattered
throughout amino acid residues 165–246, mapping within the C-terminal cytoplasmic domain
of BAP31 (Figs 2F and 3F). Taken together, the results suggest that the C-terminal domain
(residues 165–246) of cell surface-expressed BAP31 is exposed on the extracellular side. On the
other hand, cell surface-expressed BAP31 was not recognized by the goat and mouse anti-
BAP31 antibodies specific for residues 125–161 (Fig 6), although the epitope regions of the
Table 2. Prediction of transmembrane helices and topology of cell surface-expressed BAP31.
Positions Segments
1–10 Inside region 1
11–29 Transmembrane domain 1
30–45 Outside region 1
46–63 Transmembrane domain 2
64–104 Inside region 2
105–122 Transmembrane domain 3
123–246 Outside region 2
doi:10.1371/journal.pone.0130670.t002
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antibodies are also predicted to be on the extracellular side (Table 2). It is possible to speculate
that the region is not available to the antibodies because it is associated with neighboring mole-
cules on the cell surface. Another possibility is that the epitopes of the antibodies are simply
inaccessible in the native conformation of BAP31. A proposed model for cell surface-expressed
BAP31 is presented (Fig 7).
Secretory and membrane proteins enter the membrane trafficking system by translocation
from the cytoplasm into the ER, and proteins are packaged into carrier vesicles that deliver pro-
teins to the Golgi complex and sorted into secretory vesicles, which transport proteins to the
plasma membrane [27]. The cytoplasmic region of membrane proteins remains on the cyto-
plasmic side during the process of cell surface translocation [20, 27]. Unexpectedly, the present
study suggests another membrane topology for BAP31, which is different from the previous
finding (Fig 7) [3]. The phenomenon can be explained by the multiple topologies of BAP31.
Many studies have shown that multiple or dynamic topologies are found in some membrane
proteins, such as cystic fibrosis transmembrane conductance regulator, ductin, aquaporin-1,
and P-glycoprotein [28–34]. Even though the functions of multiple topological proteins are not
clearly identified [28, 34], different topologies may be associated with different functions. Our
previous finding showed that cell surface-expressed BAP31 colocalizes with EpCAM [19], sug-
gesting that the function of cell surface-expressed BAP31 may be associated with EpCAM. The
exact role of cell surface-expressed BAP31 remains to be determined.
Supporting Information
S1 Fig. Epitope mapping of the goat polyclonal anti-BAP31 antibody. (A) Schematic dia-
gram of recombinant BAP31 fragments (residues 1–124, 1–158, 1–164, 1–207, and 1–246)
used in this study. (B,C) Individual fusion proteins were expressed in bacteria as fusion pro-
teins with GST tag at the N-terminus and transferred to nitrocellulose membranes after
SDS-PAGE. GST fusion proteins were analyzed by western blots with anti-GST antibody (B)
and the goat polyclonal anti-BAP31 antibody (C), specific for the internal region of BAP31.
The asterisks indicate partial degradation products of GST-BAP31 fusion proteins.
(TIF)
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